The activity of bitter taste receptors may stimulate intestinal motility to promote gastric acid secretion, stimulate enteroendocrine cells to secrete pancreatic glucagon, and reduce lipopolysaccharide-mediated release of interleukin-6 (IL-6) from white blood cells, thus affecting cancer development. This evidence concerns the gene IL6 and cancer.